double blind placebo

Related by string. Double Blind Placebo * doubles . dou ble . Double . Doubles : double decker bus . More Than Doubles . double digit percentages / BLIND . Bed Liner . BLIN : blind placebo controlled . blind eye . Blind Side / placebos . Placebo . Placebos : randomized placebo controlled . placebo controlled clinical trials . placebo controlled * Randomized Double Blind Placebo *

Related by context. Frequent words. (Click for all words.) 87 randomized double 83 blind randomized placebo 82 placebo controlled 80 randomized placebo controlled 77 blind randomized 76 blind placebo controlled 76 randomized controlled 73 randomized 72 multicenter 71 prospective randomized 70 randomized clinical 69 dose escalation study 69 Phase IIa 67 randomized controlled trial 66 Phase IIb 66 Phase 2a clinical 66 Phase 2b clinical 65 clinical trial 65 tolerability 65 Phase IIb trial 65 Phase III clinical 64 safety tolerability 64 Phase Ib 63 multicenter study 63 Phase IIb clinical 63 pivotal Phase III 63 Phase IIa clinical 63 pharmacokinetics 63 Phase 2b 62 pharmacokinetic 62 Phase 2a 62 prospective cohort 62 pivotal Phase 61 randomized Phase 61 Phase 1b 60 dose escalation 60 Phase III 60 randomized controlled trials 59 mg dose 59 randomized clinical trials 58 observational study 58 Phase III clinical trials 58 pharmacokinetic profile 58 dosing regimens 57 randomized trials 56 relapsing remitting multiple sclerosis 56 primary endpoint 55 pharmacodynamic 55 Phase III trials 55 non inferiority 55 evaluable patients 55 dose regimen 55 dosing 55 clinical trials 55 tolerability profile 54 dosing regimen 54 primary efficacy endpoint 54 investigational drug 54 PRX # 54 Phase II 54 monotherapy 53 Efficacy 53 placebo 53 observational studies 53 efficacy 53 oral formulation 53 etanercept 53 post hoc 52 RG# [001] 52 TMC# [001] 52 ADX# 52 Clinical Trial 52 Clinical Study 52 antiviral activity 52 secondary endpoints 52 relapsing remitting MS 52 rosuvastatin 51 demonstrated statistically significant 51 n = 51 DSMB 51 pegylated interferon 51 randomly assigned 51 secondary endpoint 51 immunogenicity 51 postmenopausal women 51 laquinimod 51 Phase 51 meta analysis 50 primary endpoints 50 severe psoriasis 50 evaluable 50 mg 50 sunitinib 50 initiate Phase 50 docetaxel 49 ARRY 49 RDEA# 49 valproate 49 orally administered 49 Locteron 49 mcg

Back to home page